Transport Pharmaceuticals, Inc. Deals and Alliances Profile Introduction Transport Pharmaceuticals, Inc. (Transport Pharmaceuticals) is a clinical stage company, engaged in the convergence of drugs and medical devices for the topical treatment of dermatological conditions. The company 's product SoloVir Electrokinetic Transdermal System (ETS) for the treatment of herpes labialis. SoloVir ETS is based on the combination of Transport's proprietary acyclovir formulation and Iontophoresis, which is a type of electrokinetic delivery. The company also provides pre-clinical and clinical-stage products for onychomycosis, acne, actinic keratosis, psoriasis, keloids and warts. Transport Pharmaceuticals is headquartered in Massachusetts, the US Global Market Directs Transport Pharmaceuticals, Inc. Deals and Alliances Profile is the essential source for company data and information. The profile examines the companys key business structure and operations, history and products, as well as highlights the companys major recent financial deals. Scope Provides all the crucial company information required for business and competitor intelligence needs Gives information on the companys major recent financial deals. Data is supplemented with details on the companys history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.Reasons to Purchase Obtain up to date company information. Support sales activities by understanding your customers businesses. Qualify prospective partners and suppliers. Understand and respond to your competitors business structure, strategy and prospects.
|
